Company / AR per Share
Sunshine Biopharma Inc. AR per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$1.34
FY2025
5-year range
$0.00 / $276.08
FY2021-FY2025
Trend
-99.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2020 to $276.08 in FY2024.
Based on SEC 10-K filings.
1.34 in FY2025 with a 5-year CAGR of +656.2%.
Improved from $0.11 to $1.34 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +22.0%
- 5-Year CAGR
- +656.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, ar per share decreased 99.5% year-over-year.
- Peak ar per share was recorded in FY2024.
- Lowest ar per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.34 | -99.5% |
| FY2024 | $276.08 | +244199.9% |
| FY2023 | $0.11 | -84.7% |
| FY2022 | $0.74 | +16290.9% |
| FY2021 | $0.00 | +8199.2% |
| FY2020 | $0.00 | -46.0% |
| FY2019 | $0.00 | -95.1% |
| FY2018 | $0.00 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026